• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于双变量克莱顿 copula 模型下左截断竞争风险数据的贝叶斯参数估计。

Bayesian parametric estimation based on left-truncated competing risks data under bivariate Clayton copula models.

作者信息

Michimae Hirofumi, Emura Takeshi, Miyamoto Atsushi, Kishi Kazuma

机构信息

School of Pharmacy, Department of Clinical Medicine (Biostatistics), Kitasato University, Tokyo, Japan.

Biostatistics Center, Kurume University, Kurume, Japan.

出版信息

J Appl Stat. 2024 Feb 22;51(13):2690-2708. doi: 10.1080/02664763.2024.2315458. eCollection 2024.

DOI:10.1080/02664763.2024.2315458
PMID:39290358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404384/
Abstract

In observational/field studies, competing risks and left-truncation may co-exist, yielding 'left-truncated competing risks' settings. Under the assumption of independent competing risks, parametric estimation methods were developed for left-truncated competing risks data. However, competing risks may be dependent in real applications. In this paper, we propose a Bayesian estimator for both independent competing risks and copula-based dependent competing risks models under left-truncation. The simulations show that the Bayesian estimator for the copula-based dependent risks model yields the desired performance when competing risks are dependent. We also comprehensively explore the choice of the prior distributions (Gamma, Inverse-Gamma, Uniform, half Normal and half Cauchy) and hyperparameters via simulations. Finally, two real datasets are analyzed to demonstrate the proposed estimators.

摘要

在观察性/实地研究中,竞争风险和左截断可能同时存在,产生“左截断竞争风险”情况。在独立竞争风险的假设下,针对左截断竞争风险数据开发了参数估计方法。然而,在实际应用中竞争风险可能是相关的。在本文中,我们针对左截断情况下的独立竞争风险模型和基于 copula 的相关竞争风险模型提出了一种贝叶斯估计器。模拟结果表明,当竞争风险相关时,基于 copula 的相关风险模型的贝叶斯估计器具有理想的性能。我们还通过模拟全面探讨了先验分布(伽马分布、逆伽马分布、均匀分布、半正态分布和半柯西分布)和超参数的选择。最后,分析了两个真实数据集以展示所提出的估计器。

相似文献

1
Bayesian parametric estimation based on left-truncated competing risks data under bivariate Clayton copula models.基于双变量克莱顿 copula 模型下左截断竞争风险数据的贝叶斯参数估计。
J Appl Stat. 2024 Feb 22;51(13):2690-2708. doi: 10.1080/02664763.2024.2315458. eCollection 2024.
2
Estimation of reinforced urn processes under left-truncation and right-censoring.左截断和右删失情况下强化瓮过程的估计
R Soc Open Sci. 2023 Mar 8;10(3):221223. doi: 10.1098/rsos.221223. eCollection 2023 Mar.
3
Semiparametric copula method for semi-competing risks data subject to interval censoring and left truncation: Application to disability in elderly.半参数 Copula 方法在区间截断和左截断的半竞争风险数据中的应用:在老年人残疾中的应用。
Stat Methods Med Res. 2023 Apr;32(4):656-670. doi: 10.1177/09622802221133552. Epub 2023 Feb 3.
4
Two-stage pseudo maximum likelihood estimation of semiparametric copula-based regression models for semi-competing risks data.半竞争风险数据的半参数基于copula回归模型的两阶段伪最大似然估计
Lifetime Data Anal. 2025 Jan;31(1):52-75. doi: 10.1007/s10985-024-09640-z. Epub 2024 Oct 23.
5
Bayesian bivariate survival analysis using the power variance function copula.使用幂方差函数Copula的贝叶斯双变量生存分析。
Lifetime Data Anal. 2018 Apr;24(2):355-383. doi: 10.1007/s10985-017-9396-1. Epub 2017 May 23.
6
E-Bayesian Estimation for the Weibull Distribution under Adaptive Type-I Progressive Hybrid Censored Competing Risks Data.自适应I型渐进混合删失竞争风险数据下威布尔分布的经验贝叶斯估计
Entropy (Basel). 2020 Aug 17;22(8):903. doi: 10.3390/e22080903.
7
A two-level copula joint model for joint analysis of longitudinal and competing risks data.用于纵向和竞争风险数据联合分析的两层 Copula 联合模型。
Stat Med. 2023 May 30;42(12):1909-1930. doi: 10.1002/sim.9704. Epub 2023 Mar 7.
8
Bivariate copula regression models for semi-competing risks.双变量 Copula 回归模型在半竞争风险中的应用。
Stat Methods Med Res. 2023 Oct;32(10):1902-1918. doi: 10.1177/09622802231188516. Epub 2023 Aug 9.
9
Efficient estimation for left-truncated competing risks regression for case-cohort studies.病例-队列研究中左截断竞争风险回归的有效估计。
Biometrics. 2024 Jan 29;80(1). doi: 10.1093/biomtc/ujad008.
10
Fitting a shared frailty illness-death model to left-truncated semi-competing risks data to examine the impact of education level on incident dementia.将共享脆弱性疾病-死亡模型拟合到左截断的半竞争风险数据中,以研究教育水平对新发痴呆症的影响。
BMC Med Res Methodol. 2021 Jan 11;21(1):18. doi: 10.1186/s12874-020-01203-8.

本文引用的文献

1
Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study.晚期肺癌和特发性间质性肺炎的化疗与最佳支持治疗:一项回顾性多中心队列研究。
Respir Investig. 2023 Mar;61(2):284-295. doi: 10.1016/j.resinv.2022.10.009. Epub 2022 Dec 7.
2
Selection bias due to delayed comprehensive genomic profiling in Japan.由于在日本延迟进行全面基因组分析导致的选择偏倚。
Cancer Sci. 2023 Mar;114(3):1015-1025. doi: 10.1111/cas.15651. Epub 2022 Nov 27.
3
Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.考虑死亡的竞争风险预测 4 期慢性肾脏病成人的肾衰竭。
JAMA Netw Open. 2021 May 3;4(5):e219225. doi: 10.1001/jamanetworkopen.2021.9225.
4
Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.在生存数据分析中忽略竞争事件可能会导致有偏的结果:竞争风险分析的非数学说明。
J Clin Epidemiol. 2020 Jun;122:42-48. doi: 10.1016/j.jclinepi.2020.03.004. Epub 2020 Mar 9.
5
An approach to model clustered survival data with dependent censoring.一种用于对具有相依删失的聚类生存数据进行建模的方法。
Biom J. 2020 Jan;62(1):157-174. doi: 10.1002/bimj.201800391. Epub 2019 Nov 14.
6
Permutation Tests for General Dependent Truncation.一般相依截断的排列检验
Comput Stat Data Anal. 2018 Dec;128:308-324. doi: 10.1016/j.csda.2018.07.012. Epub 2018 Jul 29.
7
Transformation model estimation of survival under dependent truncation and independent censoring.相依删失和独立删失下生存的变换模型估计。
Stat Methods Med Res. 2019 Dec;28(12):3785-3798. doi: 10.1177/0962280218817573. Epub 2018 Dec 13.
8
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2- metastatic breast cancer.无进展生存期/疾病进展时间作为激素受体阳性、人表皮生长因子受体2阴性转移性乳腺癌总生存期的潜在替代指标。
Breast Cancer (Dove Med Press). 2018 May 4;10:69-78. doi: 10.2147/BCTT.S162841. eCollection 2018.
9
TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials.以总缓解率作为分子靶向治疗晚期肝细胞癌的替代终点:随机对照试验的荟萃分析
Br J Cancer. 2016 Nov 8;115(10):1201-1205. doi: 10.1038/bjc.2016.322. Epub 2016 Oct 13.
10
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.存在竞争风险时生存数据的分析导论
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.